NO972253L - Antitrombotisk middel og anti-von Willebrand faktor monoklonalt antistoff - Google Patents

Antitrombotisk middel og anti-von Willebrand faktor monoklonalt antistoff

Info

Publication number
NO972253L
NO972253L NO972253A NO972253A NO972253L NO 972253 L NO972253 L NO 972253L NO 972253 A NO972253 A NO 972253A NO 972253 A NO972253 A NO 972253A NO 972253 L NO972253 L NO 972253L
Authority
NO
Norway
Prior art keywords
monoclonal antibody
von willebrand
willebrand factor
antithrombotic agent
action
Prior art date
Application number
NO972253A
Other languages
English (en)
Other versions
NO319738B1 (no
NO972253D0 (no
Inventor
Mitsuyo Nagano
Hiroshi Yamamoto
Morikazu Kito
Ryota Yoshimoto
Tsuyoshi Kobayashi
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of NO972253D0 publication Critical patent/NO972253D0/no
Publication of NO972253L publication Critical patent/NO972253L/no
Publication of NO319738B1 publication Critical patent/NO319738B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO19972253A 1994-11-30 1997-05-16 Monoklonalt antistoff mot von Willebrand-faktor, antitrombotisk middel inneholdende dette som aktiv ingrediens, og hybridom som produserer et slikt antistoff NO319738B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29707094 1994-11-30
PCT/JP1995/002435 WO1996017078A1 (en) 1994-11-30 1995-11-29 Antithrombotic agent and anti-von willebrand factor monoclonal antibodies

Publications (3)

Publication Number Publication Date
NO972253D0 NO972253D0 (no) 1997-05-16
NO972253L true NO972253L (no) 1997-07-29
NO319738B1 NO319738B1 (no) 2005-09-12

Family

ID=17841828

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972253A NO319738B1 (no) 1994-11-30 1997-05-16 Monoklonalt antistoff mot von Willebrand-faktor, antitrombotisk middel inneholdende dette som aktiv ingrediens, og hybridom som produserer et slikt antistoff

Country Status (13)

Country Link
US (3) US5916805A (no)
EP (1) EP0795608B1 (no)
JP (1) JP3331377B2 (no)
KR (1) KR100406072B1 (no)
CN (1) CN1254275C (no)
AT (1) ATE236993T1 (no)
DE (1) DE69530316T2 (no)
DK (1) DK0795608T3 (no)
ES (1) ES2197210T3 (no)
FI (1) FI119734B (no)
NO (1) NO319738B1 (no)
PT (1) PT795608E (no)
WO (1) WO1996017078A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100406072B1 (ko) 1994-11-30 2004-03-30 아지노모토 가부시키가이샤 항혈전제 및 항-폰빌레브란트인자 모노클로날항체
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
US6228360B1 (en) 1998-08-19 2001-05-08 Ajinomoto Co., Inc. Antithrombotic agent and humanized anti-von Willebrand factor monoclonal antibody
JP2002529373A (ja) 1998-10-23 2002-09-10 ザ ブリガム アンド ウィメンズ ホスピタル，インコーポレイテッド コンホメーション特異的抗ｖｏｎＷｉｌｌｅｂｒａｎｄ因子抗体
CN1198198C (zh) * 2001-02-27 2005-04-20 索尼公司 字符输入方法及字符输入装置
JP2005298336A (ja) * 2002-01-29 2005-10-27 Ajinomoto Co Inc 炎症性疾患治療用薬剤
US20050136056A1 (en) * 2002-07-29 2005-06-23 Shunsuke Kageyama Pharmaceutical composition for the treatment of thrombocytopenia
AU2003252701A1 (en) * 2002-07-29 2004-02-16 Ajinomoto Co., Inc. Medicinal composition for treating thrombopenia
AU2003251238A1 (en) * 2002-08-07 2004-02-25 Umc Utrecht Holding B.V. Modulation of platelet adhesion based on the surface exposed beta-switch loop of platelet glycoprotein ib-alpha
US20110123529A1 (en) * 2002-11-08 2011-05-26 Ablynx N.V. Single domain antibodies directed against epidermal growth factor receptor and uses therefor
US20060034845A1 (en) * 2002-11-08 2006-02-16 Karen Silence Single domain antibodies directed against tumor necrosis factor alpha and uses therefor
EP1558645B1 (en) * 2002-11-08 2011-07-27 Ablynx N.V. Stabilized single domain antibodies in pharmaceutical composition adapted for inhalation
EP1900753B1 (en) * 2002-11-08 2017-08-09 Ablynx N.V. Method of administering therapeutic polypeptides, and polypeptides therefor
US9320792B2 (en) 2002-11-08 2016-04-26 Ablynx N.V. Pulmonary administration of immunoglobulin single variable domains and constructs thereof
US20100003253A1 (en) * 2002-11-08 2010-01-07 Ablynx N.V. Single domain antibodies directed against epidermal growth factor receptor and uses therefor
NZ576284A (en) * 2003-01-10 2010-07-30 Ablynx Nv Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation
JP2006517789A (ja) * 2003-01-10 2006-08-03 アブリンクス エン．ヴェー． 治療用ポリペプチド、その相同物、その断片、および血小板媒介凝集の調節での使用
CN1323713C (zh) * 2003-07-07 2007-07-04 张新侯 可溶性p－选择素及炭疽致死毒素的新用途
KR20070101226A (ko) * 2004-09-07 2007-10-16 아케믹스 코포레이션 앱타머의 약화학
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
EP1789096A4 (en) 2004-09-07 2009-07-08 Archemix Corp APTAMERS FOR THE VON WILLEBRAND FACTOR AND ITS USE AS THERAPEUTICS FOR THROMBOTIC DISEASES
WO2006074947A2 (en) 2005-01-14 2006-07-20 Ablynx N.V. METHODS AND ASSAYS FOR DISTINGUISHING BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND/OR BY SPONTANEOUS INTERACTION BETWEEN VON WILLEBRAND FACTOR (vWF) AND PLATELETS
ES2694247T3 (es) * 2005-05-20 2018-12-19 Ablynx N.V. NanobodiesTM mejorados para el tratamiento de trastornos mediados por agregación
EP1918302A3 (en) * 2006-05-18 2009-11-18 AvantGen, Inc. Methods for the identification and the isolation of epitope specific antibodies
US8669045B2 (en) 2007-02-13 2014-03-11 Ajinomoto Co., Inc. Method for inactivating viruses with slightly acidic arginine
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
AR070141A1 (es) * 2008-01-23 2010-03-17 Glenmark Pharmaceuticals Sa Anticuerpos humanizados especificos para el factor von willebrand
EP2252303A2 (en) * 2008-03-21 2010-11-24 Ablynx NV Von willebrand factor specific binders and methods of use therefor
CN102089319B (zh) 2008-05-08 2013-11-13 味之素株式会社 蛋白质的重折叠方法
CN102532316B (zh) * 2010-12-24 2014-06-18 神州细胞工程有限公司 一种抗vWF单克隆抗体及其应用
WO2012176919A1 (ja) 2011-06-23 2012-12-27 味の素株式会社 免疫グロブリン折りたたみ構造を持つタンパク質と、サブユニット構造となりうるタンパク質とを融合させた単量体タンパク質からなる多量体タンパク質の調製方法
EP3084437B1 (en) * 2013-12-18 2018-02-28 Siemens Healthcare Diagnostics Inc. Detection of endothelial disease
US10544231B2 (en) * 2014-04-16 2020-01-28 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies for the prevention or the treatment of bleeding episodes
RS66218B1 (sr) 2019-07-01 2024-12-31 Tonix Pharma Ltd Anti-cd154 antitela i njihove upotrebe
CN115087468A (zh) * 2019-12-12 2022-09-20 康宁股份有限公司 配置成影响静脉内导管上的血栓形成的光漫射元件
WO2022150452A1 (en) 2021-01-06 2022-07-14 Seth Lederman Methods of inducing immune tolerance with modified anti-cd154 antibodies
WO2025248134A1 (en) 2024-05-31 2025-12-04 Tonix Pharma Limited Treatment methods comprising administration of modified cd154 antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202264A (en) * 1989-10-27 1993-04-13 Health Research, Incorporated ELISA using multi-species antibodies for detection of von Willebrand factor in multiple species
US5342830A (en) * 1990-11-16 1994-08-30 Cor Therapeutics, Inc. Antithrombosis agents
KR100406072B1 (ko) * 1994-11-30 2004-03-30 아지노모토 가부시키가이샤 항혈전제 및 항-폰빌레브란트인자 모노클로날항체
AU724579B2 (en) 1996-04-01 2000-09-28 Sankyo Company Limited Anti-Fas recombinant antibodies and DNA therefor

Also Published As

Publication number Publication date
WO1996017078A1 (en) 1996-06-06
US20020028204A1 (en) 2002-03-07
US6280731B1 (en) 2001-08-28
DE69530316D1 (de) 2003-05-15
FI972279A0 (fi) 1997-05-29
NO319738B1 (no) 2005-09-12
KR100406072B1 (ko) 2004-03-30
US5916805A (en) 1999-06-29
EP0795608A1 (en) 1997-09-17
FI119734B (fi) 2009-02-27
ATE236993T1 (de) 2003-04-15
NO972253D0 (no) 1997-05-16
US6793920B2 (en) 2004-09-21
CN1254275C (zh) 2006-05-03
CN1174575A (zh) 1998-02-25
ES2197210T3 (es) 2004-01-01
DE69530316T2 (de) 2004-02-12
PT795608E (pt) 2003-08-29
EP0795608B1 (en) 2003-04-09
EP0795608A4 (en) 2001-11-28
FI972279L (fi) 1997-07-29
JP3331377B2 (ja) 2002-10-07
DK0795608T3 (da) 2003-07-21

Similar Documents

Publication Publication Date Title
NO972253L (no) Antitrombotisk middel og anti-von Willebrand faktor monoklonalt antistoff
SE8700498D0 (sv) Novel pharmaceologically active compounds
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
DE69431987D1 (de) Nicht-aerosol rasiergel
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
FI946004A0 (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
KR890000101A (ko) 반월조직의 치료 개선방법 및 치료약제
SE9401540L (sv) Munhygienkomposition
FR2647015B1 (fr) Gel aqueux a base d'acide retinoique et son utilisation en medecine humaine et en cosmetique
ATE188692T1 (de) Fibrinogenrezeptorantagonisten
KR930019224A (ko) 유산 위험 치료제
ATE104554T1 (de) Topische praeparate.
CA2206423A1 (en) Antithrombotic agent and anti-von willebrand factor monoclonal antibodies
ATE25195T1 (de) Verwendung von d,l- und d-carazolol zur herstellung von antiglaukommitteln sowie arzneimittel, die d-carazolol enthalten.
FI883723A7 (fi) Ihmisen monoklonaaliset vasta-aineet ja niitä vaikuttavana aineosana s isältävät terapeuttiset aineet infektiotauteja vastaan
IT1177804B (it) Composizioni per l'ignifugazione e la stabilizzazione del polietilene
FR2471184B1 (fr) Tampon chirurgical sterilisable ainsi que dispositif pour la fabrication en continu d'un tel tampon
UA9827A (uk) Пов'язка-застібка
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
IT8882203A0 (it) Procedimento e dispositivo per generare e dosare quantita'prestabile di biossido di cloro.
UA23369A (uk) Антисептичний перев`язний матеріал
RU97121764A (ru) Средство для лечения гнойно-некротических ран и ожогов "коллагель"
FI880891A7 (fi) Humaanikudoksen plasminogeenin rekombinanttiaktivaattorin koostumus.
RU97112547A (ru) Ранозаживляющий препарат

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees